← Leaderboards
Hien-Anh Nguyen
Enzyme By Design, Inc.
$353,305
Attributed
$353,305
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $298.3K · FY2018–19$500K$375K$250K$125K$0
'18
'19
Funding mix
By agency
NIH$353,305 · 1
By mechanism
R41$353,305 · 1
Top collaborators
No co-investigators on record.
Most similar at Enzyme By Design, Inc.
Same institution · by research overlap
- Amanda M Schalk$3,543,028
Others in their field
Other Emerging Leaders on “Adult Acute Lymphocytic Leukemia”
- Crystal Mackall · Children'S Hosp Of Philadelphia$10,785,733
- Amanda M Schalk · Enzyme By Design, Inc.$3,243,476
- Julie Anna Wolfson · University Of Alabama At Birmingham$2,864,905
- Ernesto Guccione · Icahn School Of Medicine At Mount Sinai$2,407,764
- Maria Grazia Roncarolo · Stanford University$2,051,333
- Hong Wen · Van Andel Research Institute$1,734,163
Research focus
Adult Acute Lymphocytic LeukemiaAsparaginaseBaseBenchmarkingBiologicalBiological Response Modifier TherapyCancer TherapyCaviaCessation Of LifeChicagoCoagulation ProcessCommercializationDesignDrug CandidateDrug KineticsEngineeringEnzymesEscherichia ColiExhibitsGlutaminaseGrantHealth PersonnelHepatotoxicityAdult
Grant awards (2)
A novel glutaminase-free mammalian asparaginase with minimized immunogenicity to enable expanded use in cancer therapy$55,000
R41 · FY2019 · CA · contact PI
A novel glutaminase-free mammalian asparaginase with minimized immunogenicity to enable expanded use in cancer therapy$298,305
R41 · FY2018 · CA · contact PI